TSX · BLCO.TO
Bausch + Lomb Corporation
CA$27.99-CA$0.76 (-2.64%)
Bausch + Lomb Corporation’s quoted price sits in the upper half of its reported 52-week range, 5.85% below the high.
Loading market information…
CNQ · CALM.CN · CAD
Stock price, earnings
Quote as of Jul 12, 2024, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · CAD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Revitalist Lifestyle and Wellness Ltd.’s next earnings report is currently expected on Nov 20, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Revitalist Lifestyle and Wellness Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Revitalist Lifestyle and Wellness Ltd. oversees a chain of medical clinics. The firm provides a comprehensive range of treatments centered on mental well-being and acupuncture, including ketamine and psychedelic-supported psychotherapy, various medicative and vitamin infusion therapies, transcranial magnetic stimulation, traditional psychotherapy, and other pharmaceutical interventions. By March 31, 2022, it had established nine clinics throughout the United States. Founded in 2018, Revitalist Lifestyle and Wellness Ltd. maintains its corporate headquarters in Vancouver, Canada.
Latest available per-share figures in CAD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:09 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CA$27.99-CA$0.76 (-2.64%)
Bausch + Lomb Corporation’s quoted price sits in the upper half of its reported 52-week range, 5.85% below the high.
CA$33.49-CA$0.18 (-0.53%)
Apotex Health Corp.’s quoted price sits in the upper half of its reported 52-week range, 16.72% below the high.
CA$0.02CA$0.00 (0.0%)
ManifestSeven Holdings Corporation: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.00$0.00 (0.0%)
Aion Therapeutic Inc.’s quoted price sits in the lower half of its reported 52-week range, 88.89% below the high.
CA$0.36CA$0.00 (0.0%)
Acerus Pharmaceuticals Corporation’s quoted price sits in the lower half of its reported 52-week range, 96.4% below the high.
CA$0.05CA$0.00 (0.0%)
Craftport Cannabis Corp.: Healthcare · Drug Manufacturers - Specialty & Generic.
CA$0.08-CA$0.01 (-11.11%)
Intellipharmaceutics International Inc.’s quoted price sits in the lower half of its reported 52-week range, 52.94% below the high.
CA$0.05CA$0.00 (0.0%)
Optima Medical Innovations Corp.: Healthcare · Medical - Care Facilities.
